Financials
Value Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses —————— — Research & development —————— — Operating income 794 M693 M770 M4.79 B1.53 B231 M 7.33 B Non-Operating Income, Total 463 M-338 M-1.46 B369 M-478 M536 M -1.04 B Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses 463 M-338 M-1.46 B369 M-478 M536 M -1.04 B Unusual income/expense —————— — Pretax income 1.15 B934 M652 M2.14 B1.38 B191 M 4.36 B Equity in earnings -46 M67 M217 M-101 M45 M162 M 323 M Taxes 71 M175 M-34 M266 M479 M1.67 B 2.38 B Non-controlling/minority interest 64 M294 M222 M619 M375 M456 M 1.67 B After tax other income/expense —————— — Net income before discontinued operations 1.01 B465 M464 M1.26 B523 M-1.94 B 308 M Discontinued operations —————— — Net income 1.01 B465 M464 M1.26 B523 M-1.94 B 308 M Dilution adjustment 000000 0 Preferred dividends 45 M45 M-39 M36 M35 M35 M 67 M Diluted net income available to common stockholders 970 M420 M503 M1.22 B488 M-1.97 B 241 M Basic earnings per share (Basic EPS) —————— — Diluted earnings per share (Diluted EPS) —————— — Average basic shares outstanding —————— — Diluted shares outstanding —————— — EBITDA 815 M1.41 B811 M4.88 B1.66 B246 M 7.6 B EBIT 794 M693 M770 M4.79 B1.53 B231 M 7.33 B Cost of revenue 3.45 B3.15 B3.13 B3.57 B6.01 B3.97 B 16.68 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) 21 M41 M41 M83 M132 M15 M 271 M